These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 12702581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ, Grundy P, Polychronakos C.
    Oncogene; 1997 Mar 06; 14(9):1041-6. PubMed ID: 9070652
    [Abstract] [Full Text] [Related]

  • 4. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP.
    Nat Genet; 1994 Jul 06; 7(3):433-9. PubMed ID: 7920665
    [Abstract] [Full Text] [Related]

  • 5. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH, Hoffman A.
    J Biol Chem; 1996 Apr 12; 271(15):9014-23. PubMed ID: 8621549
    [Abstract] [Full Text] [Related]

  • 6. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ.
    Oncogene; 1995 Jul 20; 11(2):221-9. PubMed ID: 7624139
    [Abstract] [Full Text] [Related]

  • 7. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
    Ohlsson R, Cui H, He L, Pfeifer S, Malmikumpu H, Jiang S, Feinberg AP, Hedborg F.
    Cancer Res; 1999 Aug 15; 59(16):3889-92. PubMed ID: 10463576
    [Abstract] [Full Text] [Related]

  • 8. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
    Taniguchi T, Schofield AE, Scarlett JL, Morison IM, Sullivan MJ, Reeve AE.
    Oncogene; 1995 Aug 17; 11(4):751-6. PubMed ID: 7651739
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE.
    Oncogene; 1999 Dec 09; 18(52):7527-34. PubMed ID: 10602511
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH, Duan JX, Vu TH, Hoffman AR.
    J Biol Chem; 1996 Nov 01; 271(44):27863-70. PubMed ID: 8910385
    [Abstract] [Full Text] [Related]

  • 12. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
    Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE.
    Nature; 1993 Apr 22; 362(6422):749-51. PubMed ID: 8097018
    [Abstract] [Full Text] [Related]

  • 13. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue.
    Soejima H, McLay J, Hatada I, Mukai T, Jinno Y, Niikawa N, Yun K.
    Lab Invest; 1998 Jan 22; 78(1):19-28. PubMed ID: 9461119
    [Abstract] [Full Text] [Related]

  • 14. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism.
    Ogawa O, Becroft DM, Morison IM, Eccles MR, Skeen JE, Mauger DC, Reeve AE.
    Nat Genet; 1993 Dec 22; 5(4):408-12. PubMed ID: 8298652
    [Abstract] [Full Text] [Related]

  • 15. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S, Shapiro DN, Helman LJ.
    Oncogene; 1995 Dec 21; 11(12):2503-7. PubMed ID: 8545106
    [Abstract] [Full Text] [Related]

  • 16. Loss of imprinting in hepatoblastoma.
    Rainier S, Dobry CJ, Feinberg AP.
    Cancer Res; 1995 May 01; 55(9):1836-8. PubMed ID: 7728748
    [Abstract] [Full Text] [Related]

  • 17. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Watanabe N, Nakadate H, Haruta M, Sugawara W, Sasaki F, Tsunematsu Y, Kikuta A, Fukuzawa M, Okita H, Hata J, Soejima H, Kaneko Y.
    Genes Chromosomes Cancer; 2006 Jun 01; 45(6):592-601. PubMed ID: 16518847
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H, Hedborg F, He L, Nordenskjöld A, Sandstedt B, Pfeifer-Ohlsson S, Ohlsson R.
    Cancer Res; 1997 Oct 15; 57(20):4469-73. PubMed ID: 9377554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.